HS treatment significantly decreased the levels of NF-κB, TNF-α, IL-6, MDA, and Caspase-3 and markedly demonstrated protection with respect to cerebral ischemia-reperfusion in rats [8]. This evidence concerns the gene IL6 and brain ischemia.